Polyethylenimine-mediated cellular uptake, nucleus trafficking and expression of cytokine plasmid DNA
Open Access
- 8 November 2002
- journal article
- research article
- Published by Springer Nature in Gene Therapy
- Vol. 9 (23), 1627-1632
- https://doi.org/10.1038/sj.gt.3301735
Abstract
Although polyethylenimine (PEI) has been widely used as a nonviral vector, there is little mechanistic understanding on PEI-mediated delivery. Here, we studied whether the expression of murine interleukin-2 (mIL-2) plasmids could be improved by complexation with PEI at various N/P ratios, and whether the cellular uptake, nuclear translocation, and retention of plasmids could be affected by the N/P ratios. Compared with the naked mIL-2, PEI/mIL-2 complexes showed at least two orders of magnitude higher expression at Raw264 cells in the N/P ratio-dependent manner. PEI-mediated cellular uptake and nuclear trafficking of plasmids, quantitated by competitive polymerase chain reaction, also depended on the N/P ratios showing the highest cell and nuclear levels of plasmids at 10/1. The higher cellular levels of plasmid DNA after PEI-mediated delivery were also observed in other cell lines. Unlike naked plasmids, PEI/mIL-2 complexes (N/P ratios ≥4/1) showed prolonged cellular and nuclear retention of mIL-2 plasmids. The nuclear translocation and higher cellular level of plasmids given in PEI complexes were similarly observed by fluorescence microscopy. Moreover, PEI/mIL-2 complexes revealed high stability against DNase I, partly explaining the prolonged subcellular retention. These results indicate that the expression of plasmid mIL-2 might be highly enhanced by complexation with PEI and that such increased expression could be attributed by the higher cellular uptake, nuclear translocation and prolonged retention.Keywords
This publication has 17 references indexed in Scilit:
- Prolonged organ retention and safety of plasmid DNA administered in polyethylenimine complexesGene Therapy, 2001
- Interleukin 2 Gene Therapy for Prostate Cancer: Phase I Clinical Trial and Basic BiologyHuman Gene Therapy, 2001
- Combination Nonviral Cytokine Gene Therapy for Head and Neck CancerThe Laryngoscope, 2001
- Rapid crossing of the pulmonary endothelial barrier by polyethylenimine/DNA complexesGene Therapy, 2000
- Size Reduction of Galactosylated PEI/DNA Complexes Improves Lectin-Mediated Gene Transfer into HepatocytesBioconjugate Chemistry, 1999
- Metabolic instability of plasmid DNA in the cytosol: a potential barrier to gene transferGene Therapy, 1999
- Gene transfer with synthetic virus-like particles via the integrin-mediated endocytosis pathwayGene Therapy, 1999
- Liver‐directed gene transfer: a linear polyethylenimine derivative mediates highly efficient DNA delivery to primary hepatocytes in vitro and in vivoJournal of Viral Hepatitis, 1998
- Helicobacter pylori induces an array of pro‐inflammatory cytokines in human gastric epithelial cells: Quantification of mRNA for interleukin‐8, ‐1α/β, granulocyte‐macrophage colony‐stimulating factor, monocyte chemoattractant protein‐1 and tumour necrosis factor‐αJournal of Gastroenterology and Hepatology, 1997
- Different fates of phagocytosed particles after delivery into macrophage lysosomes.The Journal of cell biology, 1996